MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial
Go back to MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial| MIMEDX GROUP (NASDAQ: MDXG) | Delayed: 3.90 +0.05 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.85 | 52 Week High | $9.90 | |||
| Open | $3.86 | 52 Week Low | $6.64 | |||
| Day High | $3.93 | P/E | N/A | |||
| Day Low | $3.83 | EPS | $-0.05 | |||
| Volume | 716,451 | |||||

